Publications by authors named "Kelly D Johnson"

Claim this Profile
K
Knowledge, attitudes, and perceptions towards pneumococcal vaccines among adults in the United States.
Salini Mohanty, Jui-Hua Tsai, Ning Ning, Ana Martinez, Rishi P Verma, Kelly D Johnson

Expert Rev Vaccines· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health and economic impact of the 21-valent pneumococcal conjugate vaccine (V116) for adults in Japan: a delta price approach.
Peter P Mueller, Atsushi Tajima, Kelsie Cassell, Taizo Matsuki, Nicole Cossrow, Kelly D Johnson

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the economic impact and healthcare resource utilization of inpatient pneumococcal disease among adults: a French national claims database study.
M Doyinsola Bailey, Gaëlle Farge, Manon Breau Brunel, Salini Mohanty, Gem Roy, Kelly D Johnson

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical burden of pneumococcal disease among adults in France: A retrospective cohort study.
M Doyinsola Bailey, Gaëlle Farge, Salini Mohanty, Manon Breau-Brunel, Gem Roy, Kelly D Johnson

Hum Vaccin Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the Pneumococcal Pneumonia Epidemiology, Urine Serotyping and Mental Outcomes (PNEUMO) study Europe.
Cristina Prat-Aymerich, Lisa Hessels, Dian Karssen, Kelly D Johnson, Sebastiaan Hullegie

ERJ Open Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-Cause and Pneumococcal Community-Acquired Pneumonia Hospitalizations Among Adults in Tennessee and Georgia.
Carlos G Grijalva, Kelly D Johnson, J Jackson Resser, Cynthia G Whitney, Adrienne Baughman, Jakea Johnson

JAMA Netw Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-acquired pneumonia in hospitalized adults: long-term morbidities and their risk factors.
Jin H Han, J Jackson Resser, Adrienne Baughman, Carlos G Grijalva, Jakea Johnson, Kelly D Johnson

BMC Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care resource use and costs associated with adult pneumococcal disease in the United States from 2017 to 2019, stratified by age and health risk: a retrospective cohort study.
Nicole Cossrow, M Doyinsola Bailey, Yi-Ling Huang, Lei Ai, Salini Mohanty, Kelly D Johnson

Front Public Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, Clinical Severity, and Serotype Distribution of Pneumococcal Pneumonia Among Adults Hospitalized With Community-Acquired Pneumonia in Tennessee and Georgia, 2018-2022.
Wesley H Self, Kelly D Johnson, J Jackson Resser, Cynthia G Whitney, Adrienne Baughman, Jakea Johnson

Clin Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences and attitudes of healthcare providers towards pneumococcal vaccines for adults in the United States.
Salini Mohanty, Jui-Hua Tsai, Ning Ning, Ana Martinez, Rishi P Verma, Kelly D Johnson

Expert Rev Vaccines· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect protection in adults ≥18 years of age from pediatric pneumococcal vaccination: a review.
Elmira Flem, Celine Mouawad, Arto A Palmu, Heather Platt, Kelly D Johnson

Expert Rev Vaccines· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualification of a 21-valent pneumococcal urine antigen detection assay and development of clinical positivity cutoffs.
Arpita Choudhury, Yuhua Zhang, Junshui Ma, Ruonan Li, Radha Chamcha, Kelly D Johnson

Bioanalysis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime Health and Economic Burden of Invasive Pneumococcal Diseases Attributable to V116 Serotypes Among Adults in the United States.
Zinan Yi, Kelly D Johnson, Kwame Owusu-Edusei

Infect Dis Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions.
Junqing Liu, Linda Shoener Dunham, Kelly D Johnson

Hum Vaccin Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal vaccination coverage among US adults enrolled in Medicaid and newly diagnosed with underlying medical conditions.
Junqing Liu, Kelly D Johnson, Linda Shoener Dunham

Expert Rev Vaccines· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic burden of pneumococcal disease among adults in Sweden: A population-based register study.
Natalie Zarabi, Martina Aldvén, Sigrid Sjölander, Hanna Fues Wahl, Goran Bencina, Kelly D Johnson

PLoS One· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Pneumococcal Vaccination in Adults in Italy: Comparing New Alternatives and Exploring the Role of GMT Ratios in Informing Vaccine Effectiveness.
Vincenzo Restivo, Vincenzo Baldo, Laura Sticchi, Francesca Senese, Gian Marco Prandi, Kelly D Johnson

Vaccines (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in Germany.
Arijita Deb, Bélène Podmore, Rosemarie Barnett, Dominik Beier, Wolfgang Galetzka, Kelly D Johnson

Epidemiol Infect· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Evaluation of Trends in Antimicrobial Resistance Among Isolates From Adults in the United States.
Salini Mohanty, Kelly D Johnson, Kalvin C Yu, Janet A Watts, Vikas Gupta

Open Forum Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal vaccination coverage in individuals (16-59 years) with a newly diagnosed risk condition in Germany.
Arijita Deb, Bélène Podmore, Rosemarie Barnett, Dominik Beier, Wolfgang Galetzka, Kelly D Johnson

BMC Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S.
Anna Ostropolets, Linda Shoener Dunham, Kelly D Johnson, Junqing Liu

Vaccine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA.
Kwame Owusu-Edusei, Arijita Deb, Kelly D Johnson

Infect Dis Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA.
Kwame Owusu-Edusei, Arijita Deb, Kelly D Johnson

Infect Dis Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Vyse et al., "A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK".
Rachel Dawson, Ulrike K Buchwald, Kelly D Johnson, Laura Spowart

Expert Rev Vaccines· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of the 15-valent pneumococcal conjugate vaccine for high-risk adults in Switzerland.
Arijita Deb, Patrik Guggisberg, Thomas Mutschler, Kwame Owusu-Edusei, Goran Bencina, Kelly D Johnson

Expert Rev Vaccines· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis